E
Tvardi Therapeutics, Inc. TVRD
$28.34 $1.706.36% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024
Total Cash And Short-Term Investments -- -2.66% 37.94%
Total Receivables -- -- --
Inventory -- -- --
Prepaid Expenses -- -- -97.78%
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- --
Total Current Assets -- -- 21.13%

Total Current Assets -- -- 21.13%
Net Property, Plant & Equipment -- -- -20.63%
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- -14.06%
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- -- 16,535.29%
Total Assets -- -- 30.36%

Total Accounts Payable -- -- 35.69%
Total Accrued Expenses -- -- 412.24%
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- 10.75%
Total Finance Division Other Current Liabilities -- -- --
Total Other Current Liabilities -- -- --
Total Current Liabilities -- -- 215.97%

Total Current Liabilities -- -- 215.97%
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases -- -- -26.91%
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- -- --
Total Liabilities -- -- 1,048.12%

Common Stock & APIC -- -- 41.49%
Retained Earnings -- -- -46.78%
Treasury Stock & Other -- -- --
Total Common Equity -- -62.15% -46.85%

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- 0.00%
Preferred Stock, Others -- -- --
Total Preferred Equity -- 0.00% 0.00%

Total Common Equity -- -62.15% -46.85%
Total Preferred Equity -- 0.00% 0.00%
Total Minority Interest -- -- --
Total Equity -- -164.50% -124.01%